USFDA concludes inspection at Jubilant Pharmova’s API manufacturing facility in Nanjangud

14 Dec 2022 Evaluate

The United States Food and Drug Administration (USFDA) has concluded inspection at Jubilant Pharmova’s Active Pharmaceutical Ingredients (API) manufacturing facility at Nanjangud, India on December 13, 2022.  The US FDA has issued eight observations pursuant to the completion of the inspection. The company will submit an action plan on the observations and will engage with US FDA for next steps.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

1046.65 -18.90 (-1.77%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×